Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 8, 2021British Journal of AnaesthesiaOpen Access

Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment

View Full Paper
Ask AI
Bookmark
Share

Authors

TSThomas StöhrResearch Center Pharmaceutical Engineering (Austria)PCPieter ColinUniversity Medical Center GroningenJOJoachim OssigPaion (Germany)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Stöhr et al. (2021) studied this question.

synapsesocial.com/papers/69efcaa4daa5208b6cb0bb4fhttps://doi.org/10.1016/j.bja.2021.05.027
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1A Placebo- and Midazolam-Controlled Phase I Single Ascending-Dose Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of Remimazolam (CNS 7056)2012 · 220 citations